Events

**We are excited to announce that the ISPE Foundation is offering grants to 20 students around the Boston area to attend the upcoming 2022 ISPE Biotechnology conference from June 28-30, 2022. These grants are first come first served so you are encouraged to apply right away.**

Please click this link to apply for the grant: 2022 ISPE Biotechnology Conference | ISPE Foundation

The 2022 ISPE Biotechnology Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists and international regulators to network, share insights and provide an outlook on the evolving landscape and future of Biopharmaceutical manufacturing and therapies. This year in particular the industry rallied together bring forward innovation at records and partnered in ways that were unprecedented to address not only the public health crisis brought on by the pandemic, but also to ensure patients worldwide would continue to have access to necessary therapies.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical and biopharmaceutical value chain to present recent innovations and trends, and openly discuss practical challenges and solutions, from a technical, logistical and regulatory perspective. The impact of the evolving regulatory environment, and the need to ensure continued innovation and continuity of the supply chain in light of this crisis and assuring preparedness for future crisis will be integrated throughout the conference program and panel discussions. Participants will have the opportunity to engage with industry leaders, regulators and peers through networking events and conference programs.

Click HERE to join us for an invigorating program and register today.

Learning Objectives

• Vaccines Development, Manufacturing, Distribution –accelerated development and approval
• Research and Development challenges for Cell and Gene Therapy, Data and Process Science
• Technology Transfer and Operations Readiness, Case studies
• Manufacturing and Quality for Cell and Gene Therapy Products and ATMP
• Continuous Manufacturing for mABs, Technology Enablers, Rationalization
• Pharma 4.0 in Biotechnology, Robotics, Digitalization and Validation

Featured Keynote Speaker:

• 

  Peter Marks, MD
  
  Director, Center for Biologics Evaluation and Research (CBER), FDA
• 

  Narendra B. Bam
  

  Vice President, GlaxoSmithKline
• 1

Why Attend?

• How to prepare successful Biopharmaceutical Operations
• How to unlock opportunities given by Digitisation
• Learn from Covid-19 challenges and resiliency

Who Should Attend?

• Professionals at all levels of the industry from young professionals to the most senior executives
• Developers, Manufacturing and Engineering professionals involved in or interested in understanding the current state of biopharmaceutical production
• Suppliers
• Quality Assurance and Regulatory professionals
• Process and Project Engineers o Regulators
• Academia
• Stakeholders of the Vaccination value chain
• **Students in the Boston area (link to grant application at top of page)